Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Science (New York, N.Y.)|November 4, 1994
p53 status and the efficacy of cancer therapy in vivoS W Lowe, S Bodis, A McClatchey, et al.Molecular Cell|March 11, 2000
Nf1 and Gmcsf interact in myeloid leukemogenesisR A Birnbaum, A O'Marcaigh, Z Wardak, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 1, 1997
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosisJ M Jones, L Attardi, L A Godley, et al.Endocrinology|February 1, 1994
Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beaglesG Hickey, T Jacks, F Judith, et al.The Journal of Endocrinology|November 1, 1994
Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beaglesT Jacks, G Hickey, F Judith, et al.Nature Genetics|March 1, 1997
A mouse model for the learning and memory deficits associated with neurofibromatosis type IA J Silva, P W Frankland, Z Marowitz, et al.Somatic Cell and Molecular Genetics|May 1, 1993
Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubulesP E Gregory, D H Gutmann, A Mitchell, et al.Nature|October 26, 1995
Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating proteinM Henkemeyer, D J Rossi, D P Holmyard, et al.Oncogene|December 17, 2009
Complete deletion of Apc results in severe polyposis in miceA F Cheung, A M Carter, K K Kostova, et al.Oncogene|August 30, 2001
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implicationsD A Tuveson, N A Willis, T Jacks, et al.Pageof 12